サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1448707

動物腎疾患の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Veterinary Renal Disease Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 236 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
動物腎疾患の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年02月01日
発行: Value Market Research
ページ情報: 英文 236 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物腎疾患市場の世界需要は、2023年の162億3,000万米ドルから2032年には約285億3,000万米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは6.47%です。

動物腎疾患は、動物の腎臓関連の健康問題を指します。これには、ペットと家畜の腎臓の構造と機能に影響を与える病態が含まれ、動物特有の要件に合わせてカスタマイズ型診断と治療アプローチが伴う。

市場力学

動物腎疾患市場は、主にペット人口の増加と動物医療への関心の高まりによって牽引されています。ペットの飼育数の増加、獣医療に対する意識の高まり、診断技術の進歩が市場の拡大に寄与しています。動物の腎疾患、特に高齢化したペットにおける腎疾患の流行は、効果的な診断と治療ソリューションに対する需要を強調しています。さらに、ペットの飼い主が動物のために専門的な獣医療サービスや治療に投資する意欲を持っていることが、市場の成長をさらに後押ししています。革新的な腎疾患管理ソリューションの研究開発における獣医業界の継続的な取り組みも市場情勢を形成しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、動物腎疾患の世界市場における各セグメントを包括的に評価することもできます。動物腎臓病産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

動物腎疾患の市場セグメンテーションでは、国別と地域別のセグメントに関する詳細なデータを提供することで、戦略担当者が各製品やサービスの対象層を特定し、今後のビジネスチャンスに役立てることができます。

タイプ別

  • 診断（検査キット＆消耗品、機器）
  • 治療（薬剤（NSAIDs、抗生物質、シスチン結合剤、利尿剤、その他）、治療用食品サプリメント、乳酸リンゲル液）

動物タイプ別

  • イヌ
  • ネコ
  • 牛
  • 馬
  • その他

投与経路別

  • 経口
  • 注射

適応症別

  • 腎不全
  • 慢性腎臓病（CKD）
  • 腎膀胱炎
  • 腎結石
  • 腎炎
  • その他

販売チャネル別

  • 動物病院・クリニック
  • ペット専門店
  • eコマース
  • その他

地域別分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける動物腎疾患市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 動物性腎疾患-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 動物腎疾患の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 診断（検査キット・消耗品、機器）
  • 治療（薬剤（非ステロイド性消炎鎮痛剤、抗生物質、シスチン結合剤、利尿剤、その他）、治療用サプリメント、乳酸リンゲル液）

第6章 動物腎疾患の世界市場分析：動物タイプ別

  • 動物タイプ別概要
  • 実績データと予測データ
  • 動物タイプ別分析
  • イヌ
  • ネコ
  • 牛
  • 馬
  • その他

第7章 動物腎疾患の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口
  • 注射

第8章 動物腎疾患の世界市場分析：適応症別

  • 適応症別概要
  • 実績データと予測データ
  • 適応症別分析
  • 腎不全
  • 慢性腎臓病（CKD）
  • 腎膀胱炎
  • 腎結石
  • 腎炎
  • その他

第9章 動物腎疾患の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 動物病院・クリニック
  • ペット専門店
  • eコマース
  • その他

第10章 動物腎疾患の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 動物腎疾患企業の競合情勢

  • 動物腎疾患市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Mars Inc.
  • Nestle Purina PetCare
  • Hills Pet Nutrition
  • J.M.Smucker
  • General Mills
  • Zoetis Inc.
  • Merck & Co. Inc.
  • Elanco
  • Phibro Animal Health Corporation
  • Ceva Sante Animale
  • Boehringer Ingelheim Animal Health
  • Dechra Pharmaceuticals
  • VetPharma
  • Vedco Inc.
  • Mission Pharmacal Company
  • Rayne Clinical Nutrition
  • Neogen Corporation
  • Roquette Freres
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Type (USD MN)
  • Diagnosis (Test Kits & Consumables, Instruments) Market Sales by Geography (USD MN)
  • Treatment(Drugs (NSAIDs, Antibiotics, Cystine-binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution) Market Sales by Geography (USD MN)
  • Analysis Market by Animal Type (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Bovine Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Renal Failure Market Sales by Geography (USD MN)
  • Chronic Kidney Disease (CKD) Market Sales by Geography (USD MN)
  • Renal Cystitis Market Sales by Geography (USD MN)
  • Kidney Stones Market Sales by Geography (USD MN)
  • Nephritis Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Veterinary Hospitals & Clinics Market Sales by Geography (USD MN)
  • Pet Specialty Stores Market Sales by Geography (USD MN)
  • E-Commerce Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Veterinary Renal Disease Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Renal Disease Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Renal Disease Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Animal Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Diagnosis (Test Kits & Consumables, Instruments) Market Sales by Geography (USD MN)
  • Treatment(Drugs (NSAIDs, Antibiotics, Cystine-binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution) Market Sales by Geography (USD MN)
  • Global Market Analysis by Animal Type (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Bovine Market Sales by Geography (USD MN)
  • Equine Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Renal Failure Market Sales by Geography (USD MN)
  • Chronic Kidney Disease (CKD) Market Sales by Geography (USD MN)
  • Renal Cystitis Market Sales by Geography (USD MN)
  • Kidney Stones Market Sales by Geography (USD MN)
  • Nephritis Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Veterinary Hospitals & Clinics Market Sales by Geography (USD MN)
  • Pet Specialty Stores Market Sales by Geography (USD MN)
  • E-Commerce Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113633

The global demand for Veterinary Renal Disease Market is presumed to reach the market size of nearly USD 28.53 Billion by 2032 from USD 16.23 Billion in 2023 with a CAGR of 6.47% under the study period 2024 - 2032.

Veterinary Renal Disease refers to kidney-related health issues in animals. This encompasses conditions impacting the structure and functionality of kidneys in both pets and livestock, accompanied by diagnostic and treatment approaches customized to meet the unique requirements of animals.

MARKET DYNAMICS

The veterinary renal disease market is primarily driven by the growing pet population and an increasing focus on animal healthcare. The rise in pet adoption, heightened awareness of veterinary care, and advancements in diagnostic technologies contribute to the market's expansion. The prevalence of renal diseases in animals, particularly in aging pets, underscores the demand for effective diagnostic and therapeutic solutions. Additionally, pet owners' willingness to invest in specialized veterinary services and treatments for their animals further propels market growth. The veterinary industry's continuous efforts in research and development for innovative renal disease management solutions also shape the market landscape.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary renal disease. The growth and trends of veterinary renal disease industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the veterinary renal disease market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Diagnosis (Test Kits & Consumables, Instruments)
  • Treatment(Drugs (Nsaids, Antibiotics, Cystine-Binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution)

By Animal Type

  • Canine
  • Feline
  • Bovine
  • Equine
  • Others

By Route Of Administration

  • Oral
  • Injectable

By Indication

  • Renal Failure
  • Chronic Kidney Disease (CKD)
  • Renal Cystitis
  • Kidney Stones
  • Nephritis
  • Others

By Distribution Channel

  • Veterinary Hospitals & Clinics
  • Pet Specialty Stores
  • E-Commerce
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Renal Disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Renal Disease market include Mars Inc., Nestle Purina PetCare, Hills Pet Nutrition, J.M.Smucker, General Mills, Zoetis Inc., Merck & Co., Inc., Elanco, Phibro Animal Health Corporation, Ceva Sante Animale, Boehringer Ingelheim Animal Health, Dechra Pharmaceuticals, VetPharma, Vedco Inc., Mission Pharmacal Company, Rayne Clinical Nutrition, Neogen Corporation, Roquette Freres. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . VETERINARY RENAL DISEASE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Animal Type
    • 3.7.3 Market Attractiveness Analysis By Route of Administration
    • 3.7.4 Market Attractiveness Analysis By Indication
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Diagnosis (Test Kits & Consumables, Instruments) Historic and Forecast Sales by Regions
  • 5.5 Treatment(Drugs (NSAIDs, Antibiotics, Cystine-binding Agents, Diuretics, Others), Therapeutic Food Supplements, Ringer Lactate Solution) Historic and Forecast Sales by Regions

6 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY ANIMAL TYPE

  • 6.1 Overview by Animal Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Animal Type
  • 6.4 Canine Historic and Forecast Sales by Regions
  • 6.5 Feline Historic and Forecast Sales by Regions
  • 6.6 Bovine Historic and Forecast Sales by Regions
  • 6.7 Equine Historic and Forecast Sales by Regions
  • 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Injectable Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Renal Failure Historic and Forecast Sales by Regions
  • 8.5 Chronic Kidney Disease (CKD) Historic and Forecast Sales by Regions
  • 8.6 Renal Cystitis Historic and Forecast Sales by Regions
  • 8.7 Kidney Stones Historic and Forecast Sales by Regions
  • 8.8 Nephritis Historic and Forecast Sales by Regions
  • 8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1 Overview by Distribution Channel
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Distribution Channel
  • 9.4 Veterinary Hospitals & Clinics Historic and Forecast Sales by Regions
  • 9.5 Pet Specialty Stores Historic and Forecast Sales by Regions
  • 9.6 E-Commerce Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL VETERINARY RENAL DISEASE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE VETERINARY RENAL DISEASE COMPANIES

  • 11.1. Veterinary Renal Disease Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF VETERINARY RENAL DISEASE INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Mars Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Nestle Purina PetCare
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Hills Pet Nutrition
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. J.M.Smucker
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. General Mills
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Zoetis Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Merck & Co. Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Elanco
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Phibro Animal Health Corporation
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Ceva Sante Animale
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Boehringer Ingelheim Animal Health
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Dechra Pharmaceuticals
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. VetPharma
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Vedco Inc.
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Mission Pharmacal Company
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Rayne Clinical Nutrition
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. Neogen Corporation
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Roquette Freres
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies